Lepzacitinib, a Janus kinase inhibitor, specifically targets JAK 1/3. It demonstrates an anti-inflammatory effect and efficacy in inhibiting atopic dermatitis as well as other skin diseases [1].
Molecular Weight:
355.39
CAS Number:
[2321488-47-3]
Formula:
C18H21N5O3
* VAT and and shipping costs not included. Errors and price changes excepted
